This biotechnology company develops vaccines targeting pathogens that accelerate aging processes. By addressing these pathogens, the company aims to improve long-term health and mitigate age-related decline through preventative vaccination.
Funding
Funding not disclosed
Founders
Product
Problem
Age-related diseases place a significant burden on healthcare systems, with a large percentage of the elderly population experiencing chronic conditions. Current healthcare approaches often address these conditions individually rather than targeting the underlying aging processes. Sexually transmitted infections and oral pathogens can accelerate aging processes and contribute to the development or severity of age-related diseases.
Solution
Healthspan is developing preventative vaccines designed to target pathogens that accelerate aging processes. By focusing on pathogens associated with age-related diseases, Healthspan aims to reduce the prevalence of chronic conditions and improve long-term health outcomes. Their approach leverages the science of vaccination to address the challenges associated with aging, promoting equitable health outcomes and potentially reducing healthcare costs. The company focuses on developing vaccines that target sexually transmitted infections and oral pathogens, which have been linked to various age-related diseases, including Alzheimer's disease, infertility, and cardiovascular disease.
Target Audience
The primary target audience includes individuals at risk of or affected by age-related diseases, healthcare providers, and public health organizations seeking to reduce the burden of age-related chronic conditions.
Features
- Development of preventative vaccines targeting pathogens associated with accelerated aging.
- Focus on sexually transmitted infections and oral pathogens.
- Aims to reduce the prevalence of chronic age-related conditions.
- Designed to improve long-term health outcomes through proactive vaccination.